Occlutech Holding AG

Alkem Laboratories reported 13.8% YoY revenue growth to ₹45.52 billion for Q2 FY27, with India business growing 9.5% and international sales up 22.3%. The company completed acquisition of Occlutech Ho

Board approved Q2 FY27 standalone and consolidated unaudited financial results for quarter ended September 30, 2026. Consolidated revenue grew to ₹82,921.4 million for H1 FY27 with profit after tax of